NCT00001837View on ClinicalTrials.gov

Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 1998

Study Completion Date

October 31, 2005

Conditions
Breast CancerBreast Neoplasm
Trial Locations (1)

20892

National Institutes of Health Clinical Center (CC), Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00001837 - Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients | Biotech Hunter | Biotech Hunter